Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I ...

Thermo Fisher Scientific Chief Executive Marc N. Casper said Tuesday that he had expected "moderating growth" in 2023 as the COVID-19 pandemic wound down and customers became more cautious.

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

Marc Casper is chairman, president, and CEO of Thermo Fisher Scientific, the world leader in serving science. He leads more than 100,000 colleagues globally to fulfill the company’s mission of ...

Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and ...

"Our team's excellent execution resulted in revenue performance that was ahead of our expectations, and we delivered positive revenue growth across all of our end markets," CEO Marc Casper remarked.

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

Marc Casper spoke with Jack Hough, Barron's associate editor, at the World Economic Forum in Davos. By Barrons.com 21:39 ...

Core organic revenue rose 5%. "We are in a great position to deliver excellent performance in 2025," Chief Executive Marc Casper said.

Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call.

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...